Location History:
- München, DE (2009)
- Groebenzell, DE (2010)
Company Filing History:
Years Active: 2009-2010
Title: **Ulrich Vierl: A Pioneer in Antifungal and NSAID Formulations**
Introduction
Ulrich Vierl, an accomplished inventor based in Groebenzell, Germany, has significantly contributed to the fields of medicine with his innovative formulations. With two patents to his name, he focuses on developing advanced topical treatments for fungal infections and nonsteroidal anti-inflammatory drugs (NSAIDs). His work not only showcases his ingenuity but also highlights the importance of effective drug delivery systems in enhancing therapeutic outcomes.
Latest Patents
Ulrich Vierl’s latest patents include:
1. **Topical Terbinafine Formulations and Methods of Administering Same for the Treatment of Fungal Infections**
This invention relates to topical antifungal formulations containing terbinafine or a pharmaceutically acceptable salt thereof, combined with a lipid and a surfactant. It aims to improve treatment outcomes for skin and nail fungal infections, addressing a critical need in dermatology.
2. **NSAID Formulations, Based on Highly Adaptable Aggregates, for Improved Transport Through Barriers and Topical Drug Delivery**
This patent describes novel formulations of NSAIDs utilizing complex aggregates composed of at least three amphipathic components suspended in a suitable polar liquid medium. A suitably ionized NSAID is included among these components, enhancing its ability to penetrate semi-permeable barriers, such as mammalian skin. This breakthrough allows deeper delivery of NSAIDs to targeted tissues, making it a highly desirable option for addressing pain and inflammation.
Career Highlights
Ulrich Vierl's professional journey includes valuable experience in companies such as Idea Ag and TDT Limited. His role in these organizations has further solidified his expertise in pharmaceutical formulations and innovative drug delivery techniques. His contributions are respected within the industry for their practical applications in improving patient care.
Collaborations
Throughout his career, Ulrich has had the pleasure of collaborating with notable individuals such as Gregor Cevc and John Charles Mayo. These collaborations have enriched his work, leading to advancements in the development of drug formulations that meet the evolving demands of healthcare.
Conclusion
In conclusion, Ulrich Vierl stands out as a notable inventor whose work in topical formulations for antifungal treatments and NSAIDs demonstrates a commitment to enhancing medical therapies. His innovative approaches not only address pressing health issues but also pave the way for future developments in pharmaceutical science. With a keen focus on improving drug delivery systems, Vierl continues to contribute significantly to the field of medicinal chemistry.